NCT01117870

Brief Summary

Pulsed RadioFrequency (PRF) is a relatively new technique derived from a well established and proven intervention, thermal radiofrequency (RF). Both procedures are used in the treatment of chronic pain. Unlike RF treatment, PRF does no direct damage to the nerve. During PRF treatment, electrical energy is applied with a small needle to the affected nerve using a pulsed time cycle that delivers short bursts of RF current. This study is interested in looking at the efficacy of PRF for chronic lumbar radicular pain (CLR) and to assess whether a larger scale clinical study with the same methods can be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Jul 2010

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
4.4 years until next milestone

Results Posted

Study results publicly available

March 21, 2017

Completed
Last Updated

March 21, 2017

Status Verified

January 1, 2017

Enrollment Period

1.9 years

First QC Date

May 4, 2010

Results QC Date

June 6, 2016

Last Update Submit

January 30, 2017

Conditions

Keywords

chronicpainlumbarRadicular

Outcome Measures

Primary Outcomes (2)

  • Recruitment Rate

    Expected recruitment is at least 4 patients per month. At least 80% of eligible patients fulfilling the selection criteria can be recruited. The final assessment was at the end of 15 months, at which time all the subjects were enrolled. Participants withdrawing within 4 weeks after the interventional shall not be included in the study. However participants withdrawing after 4 weeks of the intervention shall be included in the final analysis, on intention to treat principle.

    15 month point

  • Number of Participants Lost to Follow-up at 3 Months

    Patients who were lost to follow-up at 3 months were recorded.

    3 months

Secondary Outcomes (4)

  • Change in Mean Visual Analogue Scale (VAS) Scores From Baseline to 4 Weeks

    baseline (at recruitment) and at 4 Weeks

  • Assessment of Side Effects

    1 week and up to 3 months

  • Change in Oswestry Disability Index (ODI) From Baseline to 4 Week

    baseline (at recruitment) and at 4 weeks

  • Number of Participants Who Discontinued Analgesics After Intervention

    4 weeks

Study Arms (2)

Placebo

PLACEBO COMPARATOR

The needle will be continuously stimulated at a low voltage to give a sensation of PRF treatment.

Other: Placebo

Pulsed Radiofrequency

EXPERIMENTAL

PRF will be applied for 120 seconds at 42 degrees celsius.

Other: Pulsed Radiofrequency

Interventions

120 seconds at 42 degrees celsius

Pulsed Radiofrequency
PlaceboOTHER

Needle will be continuously stimulated at a low voltage to give a sensation of PRF application.

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years of age
  • CLR for at least 4 months of more, with concordant findings on either MRI and CT scan
  • VAS score of at least 60/100 at presentation
  • informed consent

You may not qualify if:

  • \< 18 years of age
  • patient refusal
  • any contraindication to neuraxial injection such as coagulation disturbance, anticoagulant therapy, bleeding disorder, or infection at site of injection
  • anatomical deformity or derangement, either congenital or surgical such as: extreme scoliosis, previous implant or instrumentation making it difficult to access the foramen as evidence by MRI, CT, or plain x-rays
  • uncontrolled diabetes or severe coronary vascular disease necessitating continuation of anticoagulation therapy
  • known history of psychiatric illness-such as depression or psychosis
  • presence of cancer accounting for present symptoms
  • patient's inability of communicate in English and inability to understand and fill out the required follow-up questionnaire and form
  • allergy to local anesthetics or steroid or contrast medium
  • any patient with a history of acute neurological weakness or neurodeficit in the affected limb in terms of measurable motor weakness or abnormal reflexes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East End Clinic, St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

Location

Related Publications (1)

  • Shanthanna H, Chan P, McChesney J, Paul J, Thabane L. Assessing the effectiveness of 'pulse radiofrequency treatment of dorsal root ganglion' in patients with chronic lumbar radicular pain: study protocol for a randomized control trial. Trials. 2012 Apr 28;13:52. doi: 10.1186/1745-6215-13-52.

MeSH Terms

Conditions

Chronic PainBack PainBronchiolitis Obliterans SyndromePain

Interventions

Pulsed Radiofrequency Treatment

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRadiofrequency TherapyRehabilitation

Results Point of Contact

Title
Dr. Harsha Shanthanna
Organization
McMaster University/ St. Joseph's Healthcare Hamilton

Study Officials

  • Harsha Shanthanna, MD

    St. Joseph's Healthcare Hamilton

    PRINCIPAL INVESTIGATOR
  • Philip Chan, MD

    St. Joseph's Healthcare Hamilton

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2010

First Posted

May 6, 2010

Study Start

July 1, 2010

Primary Completion

June 1, 2012

Study Completion

November 1, 2012

Last Updated

March 21, 2017

Results First Posted

March 21, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations